Unveiling the role of gut dysbiosis in non-alcoholic fatty liver disease

Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease

(2023) Li-ting Jin et al.   Frontiers in Cellular and Infection Microbiology

Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis

(2023) Shuangjie Yang et al.   Frontiers in Endocrinology

Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review

(2023) Federica Di Vincenzo et al.   Internal and Emergency Medicine

Involvement of Gut Microbial Metabolites Derived from Diet on Host Energy Homeostasis

(2022) Akari Nishida et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury

(2022) Cristina Rodriguez-Diaz et al.   PHARMACOLOGICAL RESEARCH

Fusobacterium nucleatum promotes the development of acute liver failure by inhibiting the NAD+ salvage metabolic pathway

(2022) Pan Cao et al.   Gut Pathogens

The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles

(2022) Zahra Moayedfard et al.   Stem Cell Research & Therapy

Comparison of gut microbiota in male MAFLD patients with varying liver stiffness

(2022) Yuheng Zhang et al.   Frontiers in Cellular and Infection Microbiology

Indole-3-acetic acid improves the hepatic mitochondrial respiration defects by PGC1a up-regulation

(2022) Chen Zhang et al.   CELLULAR SIGNALLING

Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease

(2022) Shaghayegh Khanmohammadi et al.   PHARMACOLOGICAL RESEARCH

Human gut microbiota in health and disease: Unveiling the relationship

(2022) Muhammad Afzaal et al.   Frontiers in Microbiology

Global Incidence and Prevalence of Non-alcoholic Fatty Liver Disease

(2022) Margaret LP Teng et al.   Clinical and Molecular Hepatology

Gut–Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers

(2021) Antonio Gil-Gómez et al.   SEMINARS IN LIVER DISEASE

Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review

(2021) Anna Pia Delli Bovi et al.   Frontiers in Medicine

Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches

(2021) Zahra Farzaneh et al.   Cancer Cell International

The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era

(2021) Nikolaos Spyrou et al.   SEMINARS IN CANCER BIOLOGY

Role and Mechanism of Gut Microbiota in Human Disease

(2021) Yinwei Chen et al.   Frontiers in Cellular and Infection Microbiology

Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions

(2021) Tomas Hrncir et al.   Microorganisms

Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy

(2021) Francesca Fianchi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier

(2021) Haruki Usuda et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD

(2021) Na Jiao et al.   PHYSIOLOGICAL GENOMICS

Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents

(2021) Daisuke Tokuhara   Frontiers in Nutrition

Contribution of gut microbiota to nonalcoholic fatty liver disease: Pathways of mechanisms

(2021) Farnush Bakhshimoghaddam et al.   Clinical Nutrition ESPEN

Akkermansia muciniphila Prevents Fatty Liver, Decreases Serum Triglycerides, and Maintains Gut Homeostasis

(2020) Sejeong Kim et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma

(2020) Manali Dimri et al.   Cancers

Insights into the Role of Human Gut Microbiota in Clostridioides difficile Infection

(2020) Melina Kachrimanidou et al.   Microorganisms

Interaction between microbiota and immunity in health and disease

(2020) Danping Zheng et al.   CELL RESEARCH

The Molecular and Mechanistic Insights Based on Gut–Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement

(2020) Yun Ji et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The Role of the Gut Microbiome in Energy Balance With a Focus on the Gut-Adipose Tissue Axis

(2020) Han Xiao et al.   Frontiers in Genetics

A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression

(2020) Paula Iruzubieta et al.   Journal of Clinical Medicine

Relationship between gut microbiota, gut hyperpermeability, and obesity

(2020) Amin Gasmi et al.   CURRENT MEDICINAL CHEMISTRY

New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress

(2020) Domenico Ferro et al.   Nutrients

Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease

(2020) S.R. Sharpton et al.   Cell Metabolism

Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease

(2019) Ki Tae Suk et al.   Expert Review of Gastroenterology & Hepatology

Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers

(2019) Nielson T. Baxter et al.   mBio

Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation

(2019) T. Hendrikx et al.   JOURNAL OF INTERNAL MEDICINE

Intestinal Barrier Function–Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota

(2019) Yizhe Cui et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study

(2019) Chikara Iino et al.   Hepatology International

Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease

(2019) Yiwen Zhang et al.   BMC GENOMICS

Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress

(2019) Yun Ji et al.   Nutrients

Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver Disease

(2019) Blencowe et al.   Genes

Increased liver localization of lipopolysaccharides in human and experimental non‐alcoholic fatty liver disease

(2019) Guido Carpino et al.   HEPATOLOGY

Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches

(2018) Antonella Borrelli et al.   Redox Biology

Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma

(2018) Ozlem Kutlu et al.   Canadian Journal of Gastroenterology and Hepatology

Molecular pathways of nonalcoholic fatty liver disease development and progression

(2018) Fernando Bessone et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Non-alcoholic fatty liver disease – A global public health perspective

(2018) Zobair M. Younossi   JOURNAL OF HEPATOLOGY

The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD

(2018) Taylor K. Soderborg et al.   Nature Communications

Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease

(2017) Feng Shen et al.   Hepatobiliary & Pancreatic Diseases International

Intestinal Barrier Function and the Gut Microbiome Are Differentially Affected in Mice Fed a Western-Style Diet or Drinking Water Supplemented with Fructose

(2017) Valentina Volynets et al.   JOURNAL OF NUTRITION

The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

(2017) Monica D. Chow et al.   MOLECULAR ASPECTS OF MEDICINE

Uncovering the trimethylamine-producing bacteria of the human gut microbiota

(2017) Silke Rath et al.   Microbiome

Short-chain fatty acids and inulin, but not guar gum, prevent diet-induced obesity and insulin resistance through differential mechanisms in mice

(2017) Karolin Weitkunat et al.   Scientific Reports

Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk

(2016) Weifei Zhu et al.   CELL

Gut microbiome and liver diseases

(2016) Herbert Tilg et al.   GUT

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives

(2016) Juan P. Arab et al.   HEPATOLOGY

Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach

(2016) Federica Del Chierico et al.   HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

(2016) Jérôme Boursier et al.   HEPATOLOGY

Acetate mediates a microbiome–brain–β-cell axis to promote metabolic syndrome

(2016) Rachel J. Perry et al.   NATURE

The role of the gut microbiota in NAFLD

(2016) Christopher Leung et al.   Nature Reviews Gastroenterology & Hepatology

The Intestinal Microbiota in Metabolic Disease

(2016) Anni Woting et al.   Nutrients

Revised Estimates for the Number of Human and Bacteria Cells in the Body

(2016) Ron Sender et al.   PLOS BIOLOGY

Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults

(2016) Yu-ming Chen et al.   Scientific Reports

Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease

(2016) Baohong Wang et al.   Scientific Reports

Altered fecal microbiota composition in patients with major depressive disorder

(2015) Haiyin Jiang et al.   BRAIN BEHAVIOR AND IMMUNITY

Nonalcoholic Fatty Liver Disease

(2015) Mary E. Rinella   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Gut-Associated Lymphoid Tissues in the Small Intestine, Not the Large Intestine, Play a Major Role in Oral Prion Disease Pathogenesis

(2015) David S. Donaldson et al.   JOURNAL OF VIROLOGY

Role of the Microbiota in Immunity and Inflammation

(2014) Yasmine Belkaid et al.   CELL

Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression

(2014) E. W. Rogier et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ethanol and liver: Recent insights into the mechanisms of ethanol-induced fatty liver

(2014) Jinyao Liu   WORLD JOURNAL OF GASTROENTEROLOGY

Inflammasomes and Metabolic Disease

(2013) Jorge Henao-Mejia et al.   Annual Review of Physiology

Ammonia production by human faecal bacteria, and the enumeration, isolation and characterization of bacteria capable of growth on peptides and amino acids

(2013) Anthony J Richardson et al.   BMC MICROBIOLOGY

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

(2012) Lixin Zhu et al.   HEPATOLOGY

Functional interactions between the gut microbiota and host metabolism

(2012) Valentina Tremaroli et al.   NATURE

Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease

(2012) D. Compare et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Altered intestinal tight junctions’ expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability

(2011) Stelios F. Assimakopoulos et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Choline and Risk of Neural Tube Defects in a Folate-fortified Population

(2009) Gary M. Shaw et al.   EPIDEMIOLOGY

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

(2009) Luca Miele et al.   HEPATOLOGY

The gut–liver-axis: Endotoxemia, inflammation, insulin resistance and NASH

(2008) Jürgen Siebler et al.   JOURNAL OF HEPATOLOGY